Neuphoria Therapeutics, Inc. (NEUP)
3.15
+0.09
(+2.94%)
USD |
NASDAQ |
Oct 30, 10:11
Neuphoria Therapeutics Market Cap : 17.05M for Oct. 30, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 29, 2026 | 16.56M |
| October 28, 2026 | 18.18M |
| October 27, 2026 | 18.34M |
| October 26, 2026 | 18.29M |
| October 23, 2026 | 18.61M |
| October 22, 2026 | 18.83M |
| October 21, 2026 | 18.83M |
| October 20, 2026 | 18.34M |
| October 19, 2026 | 17.91M |
| October 16, 2026 | 17.86M |
| October 15, 2026 | 17.91M |
| October 14, 2026 | 17.53M |
| October 13, 2026 | 18.34M |
| October 12, 2026 | 17.97M |
| October 09, 2026 | 18.18M |
| October 08, 2026 | 18.13M |
| October 07, 2026 | 18.51M |
| October 06, 2026 | 18.67M |
| October 05, 2026 | 18.67M |
| October 02, 2026 | 18.78M |
| October 01, 2026 | 18.99M |
| September 30, 2026 | 19.26M |
| September 29, 2026 | 19.32M |
| September 28, 2026 | 19.75M |
| September 25, 2026 | 19.75M |
| Date | Value |
|---|---|
| September 24, 2026 | 19.75M |
| September 23, 2026 | 19.91M |
| September 22, 2026 | 20.21M |
| September 21, 2026 | 20.08M |
| September 18, 2026 | 20.02M |
| September 17, 2026 | 20.10M |
| September 16, 2026 | 20.24M |
| September 15, 2026 | 20.45M |
| September 14, 2026 | 20.43M |
| September 11, 2026 | 20.06M |
| September 10, 2026 | 20.06M |
| September 09, 2026 | 20.16M |
| September 08, 2026 | 20.16M |
| September 04, 2026 | 20.27M |
| September 03, 2026 | 20.22M |
| September 02, 2026 | 20.16M |
| September 01, 2026 | 20.38M |
| August 31, 2026 | 20.22M |
| August 28, 2026 | 20.22M |
| August 27, 2026 | 20.27M |
| August 26, 2026 | 20.76M |
| August 25, 2026 | 20.76M |
| August 24, 2026 | 21.24M |
| August 21, 2026 | 21.03M |
| August 20, 2026 | 21.24M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 293.62M |
| Amgen, Inc. | 253.83B |
| Anika Therapeutics, Inc. | 291.62M |
| BioCryst Pharmaceuticals, Inc. | 2.162B |
| Imunon, Inc. | 3.998M |
Market Cap Related Metrics
| PS Ratio | 11.81 |
| Price to Book Value | 0.6929 |
| Price | 3.15 |
| Earnings Yield | -196.4% |